Close Menu

NEW YORK – Oxford Immunotec said this week that it has been selected to provide T-cell testing for SARS-CoV-2 to the UK Vaccines Taskforce, a UK government body formed to assess the suitability of vaccines for the UK population. The company said it was chosen for its T-Spot technology and its expertise in T-cell measurement. T-Spot is already used clinically to identify T cells made in response to a respiratory pathogen responsible for tuberculosis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.